Banzel

Product manufactured by Eisai Inc.

Application Nr Approved Date Route Status External Links
NDA021911 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 I Ndications And Usage Banzel Is Indicated For Adjunctive Treatment Of Seizures Associated With Lennox-Gastaut Syndrome In Pediatric Patients 1 Year Of Age And Older And In Adults. Banzel Is Indicated For Adjunctive Treatment Of Seizures Associated With Lennox-Gastaut Syndrome (Lgs) In Pediatric Patients 1 Year Of Age And Older, And In Adults ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Rufinamide RUFINAMIDE ZINC7782

Comments